Department of Infectious Diseases
Monica A. Slavin has not added Biography.
If you are Monica A. Slavin and would like to personalize this page please email our Author Liaison for assistance.
Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.
British journal of haematology Jan, 2006 | Pubmed ID: 16371014
Emerging opportunistic yeast infections in haematology patients.
Leukemia & lymphoma Sep, 2006 | Pubmed ID: 17064982
A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.
Bone marrow transplantation Jul, 2007 | Pubmed ID: 17468774
Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response.
Tuberculosis (Edinburgh, Scotland) Sep, 2007 | Pubmed ID: 17631049
Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.
European journal of haematology Sep, 2007 | Pubmed ID: 17655696
Surveillance for catheter-associated bloodstream infection in hematology units: quantifying the characteristics of a practical case definition.
Infection control and hospital epidemiology Apr, 2008 | Pubmed ID: 18462148
Bloodstream infections in haematology: risks and new challenges for prevention.
Blood reviews May, 2009 | Pubmed ID: 19046796
Risk-based antifungal prophylaxis in hematologic malignancy and stem cell transplantation.
Current infectious disease reports Nov, 2009 | Pubmed ID: 19857380
Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
The Journal of antimicrobial chemotherapy May, 2010 | Pubmed ID: 20202987
Toxoplasmosis and allogeneic stem cell transplantation: can we do better?
Leukemia & lymphoma Aug, 2010 | Pubmed ID: 20687798
Fluoroquinolone prophylaxis: a word of caution.
Leukemia & lymphoma Jan, 2011 | Pubmed ID: 21067448
Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.
Expert review of anti-infective therapy Apr, 2011 | Pubmed ID: 21504403
Anaerobes: not to be forgotten in neutropenic fever.
Leukemia & lymphoma Jun, 2011 | Pubmed ID: 21534876
Opportunistic fungal infections in the Asia-Pacific region.
Medical mycology Jan, 2012 | Pubmed ID: 21905945
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
Haematologica Mar, 2012 | Pubmed ID: 22058198
A cost analysis of febrile neutropenia management in Australia: ambulatory v. in-hospital treatment.
Australian health review : a publication of the Australian Hospital Association Nov, 2011 | Pubmed ID: 22126955
Staphylococcus aureus meningitis: barriers to treatment.
Leukemia & lymphoma Aug, 2012 | Pubmed ID: 22360718
Complications of sepsis: the role of risk prediction rules, biomarkers and host genetics.
Expert review of anti-infective therapy Jul, 2012 | Pubmed ID: 22943396
Cryptococcosis, lymphoproliferative disorders and modern day chemotherapy regimens.
Leukemia & lymphoma Mar, 2013 | Pubmed ID: 23035788
Fluoroquinolone prophylaxis: worth the cost?
Leukemia & lymphoma Apr, 2013 | Pubmed ID: 23035818
Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis.
European journal of haematology Aug, 2013 | Pubmed ID: 23668894
Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.
Antimicrobial agents and chemotherapy Sep, 2013 | Pubmed ID: 23817382
More than a feeling: new approach required for assessing immunosuppression.
Leukemia & lymphoma May, 2014 | Pubmed ID: 24286260
The prevention and management of infections due to multidrug resistant organisms in haematology patients.
British journal of clinical pharmacology Feb, 2015 | Pubmed ID: 24341410
Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection.
Blood reviews Mar, 2014 | Pubmed ID: 24582081
Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reaction.
Medical mycology May, 2014 | Pubmed ID: 24625674
Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis.
Leukemia & lymphoma Jan, 2015 | Pubmed ID: 24717111
Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Diagnostic microbiology and infectious disease Mar, 2014 | Pubmed ID: 24768294
A different kind of "allogeneic transplant": successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma.
Leukemia & lymphoma Feb, 2015 | Pubmed ID: 24828871
Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.
Haematologica Jan, 2015 | Pubmed ID: 25304609
Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia.
The Medical journal of Australia Nov, 2014 | Pubmed ID: 25358582
Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Jul, 2015 | Pubmed ID: 25487843
Candida glabrata fungaemia at an Australian cancer centre: epidemiology, risk factors and therapy.
Leukemia & lymphoma , 2015 | Pubmed ID: 25907425
The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients.
Antimicrobial resistance and infection control , 2015 | Pubmed ID: 26034582
Improving the outcome of bloodstream infection in patients with hematological malignancies: looking beyond antibiotics.
Leukemia & lymphoma , 2015 | Pubmed ID: 26088876
Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy.
British journal of haematology Oct, 2015 | Pubmed ID: 26105211
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Oct, 2015 | Pubmed ID: 26113653
Epidemiology of invasive fungal disease in lymphoproliferative disorders.
Haematologica Nov, 2015 | Pubmed ID: 26206797
Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization.
Expert review of anti-infective therapy , 2015 | Pubmed ID: 26489539
Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.
The Journal of antimicrobial chemotherapy Feb, 2016 | Pubmed ID: 26518050
Isavuconazole: a role for the newest broad-spectrum triazole.
Lancet (London, England) Feb, 2016 | Pubmed ID: 26684608
Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapies.
Leukemia & lymphoma 07, 2016 | Pubmed ID: 26727243
Aseptic technique for accessing central venous catheters: applying a standardised tool to audit 'scrub the hub' practices.
The journal of vascular access May, 2016 | Pubmed ID: 26868480
Invasive fungal infections in ALL: a new 'growth' area.
Leukemia & lymphoma Sep, 2016 | Pubmed ID: 27124301
Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.
The Journal of antimicrobial chemotherapy 12, 2016 | Pubmed ID: 27521358
Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations.
International journal of antimicrobial agents Oct, 2016 | Pubmed ID: 27562696
Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis.
European journal of cancer (Oxford, England : 1990) Nov, 2016 | Pubmed ID: 27592069
The epidemiology of Clostridium difficile infection in patients with cancer.
Expert review of anti-infective therapy Nov, 2016 | Pubmed ID: 27606976
Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.
Expert review of anti-infective therapy Dec, 2016 | Pubmed ID: 27710140
Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy.
European journal of haematology Feb, 2017 | Pubmed ID: 27717026
Improving Antimicrobial Stewardship by Antibiotic Allergy Delabeling: Evaluation of Knowledge, Attitude, and Practices Throughout the Emerging Infections Network.
Open forum infectious diseases Sep, 2016 | Pubmed ID: 27800527
Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Jun, 2017 | Pubmed ID: 28155020
Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes.
Leukemia & lymphoma Oct, 2017 | Pubmed ID: 28278704
Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Nov, 2017 | Pubmed ID: 28353037
Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience.
The Journal of antimicrobial chemotherapy Jul, 2017 | Pubmed ID: 28369489
Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers.
Vaccine 05, 2017 | Pubmed ID: 28385605
Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jul, 2017 | Pubmed ID: 28520865
Cart before the horse: use of Aspergillus PCR to increase the diagnostic yield from BAL in hematological patients at risk of invasive aspergillosis.
Leukemia & lymphoma Dec, 2017 | Pubmed ID: 28573907
Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study.
British journal of cancer Jul, 2017 | Pubmed ID: 28609435
Ibrutinib may impair serological responses to influenza vaccination.
Haematologica Oct, 2017 | Pubmed ID: 28659336
The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.
The journal of allergy and clinical immunology. In practice Nov - Dec, 2017 | Pubmed ID: 28843343
External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules.
The Pediatric infectious disease journal Sep, 2017 | Pubmed ID: 28877157
Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Oct, 2017 | Pubmed ID: 29018966
Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling.
Frontiers in immunology , 2017 | Pubmed ID: 29051761
The Combined Utility of Ex vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In vivo Skin Testing in Patients With Antibiotic-Associated Severe Cutaneous Adverse Reactions.
The journal of allergy and clinical immunology. In practice Oct, 2017 | Pubmed ID: 29100867
Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Frontiers in immunology , 2017 | Pubmed ID: 29170666
Single-centre study of therapeutic drug monitoring of posaconazole in lung transplant recipients: factors affecting trough plasma concentrations.
The Journal of antimicrobial chemotherapy Dec, 2017 | Pubmed ID: 29211913
Chayanika Biswas*,1,
Sharon C-A. Chen*,1,2,3,
Catriona Halliday1,2,
Elena Martinez1,
Rebecca J. Rockett1,
Qinning Wang1,
Verlaine J. Timms1,
Rajat Dhakal1,
Rosemarie Sadsad1,
Karina J. Kennedy4,
Geoffrey Playford4,5,
Deborah J. Marriott6,
Monica A. Slavin7,
Tania C. Sorrell1,3,
Vitali Sintchenko1,2,3
1Centre for Infectious Diseases and Microbiology-Public Health, Westmead Hospital,
2Centre for Infectious Diseases and Microbiology Laboratory Services, ICPMR,
3Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney,
4Department of Microbiology and Infectious Diseases, Canberra Hospital and Health Services, Australian National University Medical School,
5Infection Management Services, Australian National University Medical School,
6Department of Microbiology and Infectious Diseases, St. Vincent's Hospital,
7Department of Infectious Diseases, Peter MacCallum Cancer Centre